Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature.

STUDY OBJECTIVES There is some evidence that magnesium, when infused into asthmatic patients, can produce bronchodilation in addition to that obtained from standard treatments. This systematic review examined the effect of intravenous magnesium sulfate used for patients with acute asthma managed in the emergency department. METHODS Only randomized controlled trials were eligible for inclusion. Studies were included if patients presented with acute asthma and were treated with intravenous magnesium sulfate versus placebo. Trials were identified from the Cochrane Airways Review Group register, which consists of a combined search of EMBASE, MEDLINE, and CINAHL databases and hand-searching of 20 key respiratory journals. Bibliographies from included studies and known reviews were searched. Primary authors and content experts were contacted. Data were extracted and methodologic quality was assessed independently by 2 reviewers. Missing data were obtained from authors. RESULTS Seven trials (5 adult, 2 pediatric) involving a total of 668 patients were included. Overall, admission to hospital was not statistically reduced using magnesium sulfate (odds ratio [OR] 0.31, 95% confidence interval [CI] 0.09 to 1.02). In the severe subgroup, admissions were reduced in those receiving magnesium sulfate (OR 0.10, 95% CI 0.04 to 0.27). Overall, patients receiving magnesium sulfate demonstrated nonsignificant improvements in peak expiratory flow rates (PEFR) when all studies were pooled (weighted mean difference [WMD] 29 L/min, 95% CI -3 to 62). In studies of patients with severe acute asthma, PEFR WMD improved by 52 L/min (95% CI 27 to 78) favoring magnesium sulfate treatment. The absolute FEV(1) also improved by 10% predicted (95% CI 4 to 16) in patients with severe acute asthma. No clinically important changes in vital signs or side effects were reported. CONCLUSION Current evidence does not clearly support routine use of intravenous magnesium sulfate in all patients with acute asthma presenting to the ED. However, magnesium sulfate appears to be safe and beneficial for patients who present with severe acute asthma. Practice guidelines need to be changed to reflect these results.

[1]  Mark V. Williams,et al.  Users' Guides to the Medical Literature , 2002 .

[2]  Nebulized ipratropium bromide in acute pediatric asthma: does it reduce hospital admissions among children presenting to the emergency department? , 1999, Annals of emergency medicine.

[3]  B. Rowe,et al.  The Cochrane Library: a resource for clinical problem solving in emergency medicine. , 1999, Annals of emergency medicine.

[4]  S. Aaron,et al.  The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. , 1999, Annals of emergency medicine.

[5]  F. Ducharme,et al.  Should inhaled anticholinergics be added to β2 agonists for treating acute childhood and adolescent asthma? A systematic review , 1998, BMJ.

[6]  John Pestian,et al.  Effect of nebulized ipratropium on the hospitalization rates of children with asthma. , 1998, The New England journal of medicine.

[7]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[8]  M. Kohn,et al.  The acute asthmatic patient in the ED: to admit or discharge. , 1998, The American journal of emergency medicine.

[9]  J. Shani,et al.  Magnesium in the management of asthma: critical review of acute and chronic treatments, and Deutsches Medizinisches Zentrum's (DMZ's) clinical experience at the Dead Sea. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[10]  P. Wyer,et al.  Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability? , 1997, Annals of emergency medicine.

[11]  G. Grégoire,et al.  Discrepancies between meta-analyses and subsequent large randomized, controlled trials. , 1997, The New England journal of medicine.

[12]  D. Cook,et al.  A guide to interpreting discordant systematic reviews. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[13]  R. Prasad,et al.  Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. , 1997, Indian pediatrics.

[14]  C. Cairns,et al.  Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. , 1996, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[15]  M. Shannon,et al.  Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. , 1996, The Journal of pediatrics.

[16]  R. Beveridge,et al.  Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[17]  B. Littenberg,et al.  Theophylline in acute childhood asthma: A meta‐analysis of its efficacy , 1996, Pediatric pulmonology.

[18]  A. Detsky,et al.  Direct and indirect costs of asthma in Canada, 1990. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[19]  K. Ota.  [Inflammatory mediators in asthma]. , 1996, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[20]  S. Hurd,et al.  Asthma Research: Future Directions for Emergency Medicine , 1996 .

[21]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[22]  M. Sears.  Epidemiological trends in asthma , 1996 .

[23]  T. Klassen,et al.  Efficacy of ipratropium bromide in acute childhood asthma: a meta-analysis. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[24]  R. Silverman,et al.  Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. , 1995, Chest.

[25]  M. Clarke,et al.  Identifying relevant studies for systematic reviews , 1995, BMJ.

[26]  I Olkin,et al.  Statistical and theoretical considerations in meta-analysis. , 1995, Journal of clinical epidemiology.

[27]  K. Dickersin,et al.  Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .

[28]  G H Guyatt,et al.  Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. , 1994, JAMA.

[29]  N. Kissoon,et al.  Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus , 1994, Pediatric emergency care.

[30]  S. Wenzel,et al.  Asthma as an Inflammatory Disease , 1994, Annals of allergy.

[31]  R. Schiermeyer,et al.  Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus. , 1994, The American journal of emergency medicine.

[32]  P. O'Byrne.  Airway Inflammation and the Pathogenesis of Asthma , 1994 .

[33]  J. Lammers,et al.  Extracellular and intracellular magnesium concentrations in asthmatic patients. , 1993, The European respiratory journal.

[34]  I. K. Todd,et al.  Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. , 1993, Chest.

[35]  Y. Mao,et al.  Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[36]  B. H. Rowe,et al.  Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. , 1992, The American journal of emergency medicine.

[37]  J. Britton.  Asthma's changing prevalence. , 1992, BMJ.

[38]  P. Gergen,et al.  An economic evaluation of asthma in the United States. , 1992, The New England journal of medicine.

[39]  S. Rothrock,et al.  Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. , 1992, Annals of emergency medicine.

[40]  S. Fitzgerald.  National Asthma Education Program Expert Panel report: guidelines for the diagnosis and management of asthma. , 1992, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[41]  G H Guyatt,et al.  A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.

[42]  Claude Lenfant,et al.  National Asthma Education Program , 1990 .

[43]  E. Skobeloff,et al.  Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. , 1989, JAMA.

[44]  C. Bucca,et al.  Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. , 1988, Annals of allergy.

[45]  D L Sackett,et al.  An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.

[46]  G H Guyatt,et al.  Guidelines for reading literature reviews. , 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[47]  B. Littenberg.  Aminophylline treatment in severe, acute asthma. A meta-analysis. , 1988, JAMA.

[48]  R. Mathew,et al.  Magnesium and the lungs. , 1988, Magnesium.

[49]  K. Dickersin,et al.  Publication bias and clinical trials. , 1987, Controlled clinical trials.

[50]  C. Mulrow.  The medical review article: state of the science. , 1987, Annals of internal medicine.

[51]  T. Takishima,et al.  Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. , 1987, JAMA.

[52]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[53]  J. Coburn,et al.  Magnesium, the mimic/antagonist to calcium. , 1984, The New England journal of medicine.

[54]  C. Page,et al.  Inflammatory Mediators of Asthma , 1983, The Lancet.

[55]  A. Feinstein,et al.  Clinical biostatistics: LIV. The biostatistics of concordance , 1981 .

[56]  A. Feinstein,et al.  THE BIOSTATISTICS OF CONCORDANCE , 1981 .